Similar articles for PMID: 31909928

Year	Number of Results
2000	1
2003	1
2008	1
2010	2
2011	1
2012	2
2013	2
2014	4
2015	3
2016	1
2017	8
2018	10
2019	19
2020	29
2021	22
2022	1
2023	1
2024	1

1

[No authors listed] [No authors listed] London: National Institute for Health and Care Excellence (NICE); 2021 Mar 22. London: National Institute for Health and Care Excellence (NICE); 2021 Mar 22. PMID: 31909928 Free Books & Documents. Review.

2

Source of cannabinoids: what is available, what is used, and where does it come from?

Specchio N, Pietrafusa N, Cross HJ. Specchio N, et al. Epileptic Disord. 2020 Jan 1;22(S1):1-9. doi: 10.1684/epd.2019.1121. Epileptic Disord. 2020. PMID: 31941643

3

Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome.

Lattanzi S, Zaccara G, Russo E, La Neve A, Lodi MAM, Striano P. Lattanzi S, et al. Expert Rev Neurother. 2021 Jan;21(1):99-110. doi: 10.1080/14737175.2021.1834383. Epub 2020 Oct 25. Expert Rev Neurother. 2021. PMID: 33026899 Review.

4

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Devinsky O, et al. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Epilepsia. 2014. PMID: 24854329 Free PMC article. Review.

5

A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?

Cross JH, Cock H. Cross JH, et al. Neuropharmacology. 2020 Jun 15;170:107861. doi: 10.1016/j.neuropharm.2019.107861. Epub 2019 Nov 23. Neuropharmacology. 2020. PMID: 31770546 Review.

6

Medical cannabis: What practitioners need to know.

Van Rensburg R, Pillay-Fuentes Lorente V, Blockman M, Moodley K, Wilmshurst JM, Decloedt EH. Van Rensburg R, et al. S Afr Med J. 2020 Feb 26;110(3):192-196. doi: 10.7196/SAMJ.2020.v110i3.14403. S Afr Med J. 2020. PMID: 32657695

7

Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?

Khalid S, Almalki FA, Hadda TB, Bader A, Abu-Izneid T, Berredjem M, Elsharkawy ER, Alqahtani AM. Khalid S, et al. Curr Pharm Des. 2021;27(13):1564-1578. doi: 10.2174/1381612826666201202125807. Curr Pharm Des. 2021. PMID: 33267756 Review.

8

A Critical Review of the Role of the Cannabinoid Compounds Δ⁹-Tetrahydrocannabinol (Δ⁹-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment.

Jones É, Vlachou S. Jones É, et al. Molecules. 2020 Oct 25;25(21):4930. doi: 10.3390/molecules25214930. Molecules. 2020. PMID: 33113776 Free PMC article. Review.

9

Cannabis for the Treatment of Epilepsy: an Update.

Gaston TE, Szaflarski JP. Gaston TE, et al. Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y. Curr Neurol Neurosci Rep. 2018. PMID: 30194563 Review.

10

Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA. Lee D, et al. Drug Alcohol Depend. 2013 Jun 1;130(1-3):68-76. doi: 10.1016/j.drugalcdep.2012.10.011. Epub 2012 Nov 10. Drug Alcohol Depend. 2013. PMID: 23146820 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year